ClinicalTrials.gg
Drug

Irinotecan clinical trials

Also written CPT-11, Camptosar, Campto and U-101440E.

Includes 79 studies of Irinotecan sucrosofate, 2 studies of Liposomal SN-38 and 1 study of Pegylated Liposomal Irinotecan.

studies test it
786
open now
120
in phase 3
78
first study started
1995

Counted the way a researcher would: Irinotecan with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Irinotecan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Irinotecan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
14 Jun 1996 · CAMPTOSAR · NDA 020571 (FDA, Drugs@FDA)
European Union
14 Oct 2016 · Onivyde pegylated liposomal (previously Onivyde) · EMEA/H/C/004125 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Irinotecan
333
irinotecan hydrochloride
234
Liposomal Irinotecan
22
Camptothecin-11
20
nal-IRI
9

Brand

Camptosar
109
Campto
60
Onivyde
7

Development codes

CPT-11
110
U-101440E
36
PEP02
3
NKTR-102
2
NSC-616348
2

In one entry with another drug

Given together, or one or the other

Irinotecan, Capecitabine
4
NK012
3
Irinotecan and cisplatin
2
irinotecan + cisplatin
2
S-1, Irinotecan, Bevacizumab
2
Naxitamab and GM-CSF in combination with irinotecan and temozolomide
2
mFOLFIRINOX Treatment Regimen
2
S-1, irinotecan, oxaliplatin
2

Studies by the year they started

781 studies that test it; most in 2003 (45)

Studies that test Irinotecan, by start year
YearStudies
19951
19963
199710
199822
199925
200025
200131
200231
200345
200439
200531
200641
200729
200830
200930
201016
201120
201220
201323
201423
201522
201615
201722
201824
201928
202026
202126
202224
202311
202445
202521
202622

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
239
Phase 2
523
Phase 3
78
Phase 4
9
No phase
12

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 90 · Other 696

National Cancer Institute (NCI) (34) · Alliance for Clinical Trials in Oncology (28) · Memorial Sloan Kettering Cancer Center (26) · M.D. Anderson Cancer Center (15) · Children's Oncology Group (14) · Roswell Park Cancer Institute (14) · Sun Yat-sen University (13) · Pfizer (12)

Often tested with

Tested in the same studies.

Fluorouracil (144) · Oxaliplatin (126) · Leucovorin (84) · Bevacizumab (82) · Cisplatin (67) · Temozolomide (64) · Capecitabine (64) · Cetuximab (55)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 29 phase 3 studies under way

Irinotecan is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 41, 6 in phase 3

Studies that test Irinotecan, phase 3 first.

Studies

Open first, then newest update. How each study uses Irinotecan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 786

See all 786 studies that test Irinotecan →

Given beside what is tested · 433 — Irinotecan is usual care or a partner of the new treatment

Showing 20 of 433.

As the comparator · 62 — what is tested is compared with Irinotecan

Showing 20 of 62.

Codes

What other systems call Irinotecan · ClinicalTrials.gg INT006650

  • MeSH (NLM) D000077146IrinotecanConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 7673326042IRINOTECANConfirmed FDA, NLM, Wikidata
  • RxNorm 51499Confirmed FDA, Wikidata
  • Wikidata Q412197irinotecanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62040IrinotecanOne source FDA
  • DrugBank DB00762One source Wikidata

Also registered as 7-ethyl-10-hydroxycamptothecin (UNII 0H43101T0J) and irinotecan hydrochloride (UNII 042LAQ1IIS · RxNorm 153329).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.